Abstract
Since its discovery in 1984, the beta amyloid peptide has treaded the boards of neurosciences as the star molecule in Alzheimer’s disease pathogenesis. In the last decade, however, this vision has been challenged by evidence-based medicine showing the almost complete failure of clinical trials that experimented anti-amyloid therapies with great hopes. Moreover, data have accumulated which clearly indicate that this small peptide plays a key role in the physiological processes of memory formation. In the present review, we will discuss the different aspects of the amyloid cascade hypothesis, highlighting its pros and cons, and we will analyse the results of the therapeutic approaches attempted to date that should change the direction of Alzheimer’s disease research in the future.
Keywords: Alzheimer's disease, beta amyloid, clinical trials, LTP, memory, anti-amyloid therapy.
Current Neuropharmacology
Title:The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Volume: 15 Issue: 6
Author(s): Roberta Ricciarelli*Ernesto Fedele*
Affiliation:
- Department of Experimental Medicine, Section of General Pathology, University of Genova, Genova,Italy
- Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genova, Genova,Italy
Keywords: Alzheimer's disease, beta amyloid, clinical trials, LTP, memory, anti-amyloid therapy.
Abstract: Since its discovery in 1984, the beta amyloid peptide has treaded the boards of neurosciences as the star molecule in Alzheimer’s disease pathogenesis. In the last decade, however, this vision has been challenged by evidence-based medicine showing the almost complete failure of clinical trials that experimented anti-amyloid therapies with great hopes. Moreover, data have accumulated which clearly indicate that this small peptide plays a key role in the physiological processes of memory formation. In the present review, we will discuss the different aspects of the amyloid cascade hypothesis, highlighting its pros and cons, and we will analyse the results of the therapeutic approaches attempted to date that should change the direction of Alzheimer’s disease research in the future.
Export Options
About this article
Cite this article as:
Ricciarelli Roberta*, Fedele Ernesto*, The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind, Current Neuropharmacology 2017; 15 (6) . https://dx.doi.org/10.2174/1570159X15666170116143743
DOI https://dx.doi.org/10.2174/1570159X15666170116143743 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Conformational Pathology in Alzheimers and Other Neurodegenerative Diseases; New Targets for Therapy
Current Alzheimer Research The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges
Current Medicinal Chemistry Current Status of Anti-HIV Agents
Current Medicinal Chemistry - Anti-Infective Agents Epitope-Driven TB Vaccine Development: A Streamlined Approach Using Immuno-Informatics, ELISpot Assays, and HLA Transgenic Mice
Current Molecular Medicine Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Mathematical Models for the Management of Helminth Parasites: From Biological Processes to the Evolution of Anthelmintic Resistance
Anti-Infective Agents in Medicinal Chemistry Immunopotentiation for Bacterial Biodefense
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Protein Peptide Informatics and Drug Designing - Some Computational Techniques for Structural Genomics Based Approaches (Part II) (Guest Editor: Rajani R. Joshi)]
Protein & Peptide Letters Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Vaccination and Induction of Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Innovative Methodology in the Discovery of Novel Drug Targets in the Free-Living Amoebae
Current Drug Targets Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors
Current Gene Therapy Current Progress in the Development of HIV Vaccines
Current Pharmaceutical Design Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles
Current Protein & Peptide Science The Neuroscience of Maternal Behaviour
Current Psychiatry Reviews Pharmacological Perspectives of Ayurvedic Herbs <i>viz. Alstonia scholaris</i> L., <i>Picrorhiza kurroa, Swertia chirata</i> and <i>Caesalpinia crista</i> Against COVID- 19: A Mini-Review
Mini-Reviews in Organic Chemistry The Role of Immune System in Schizophrenia
Current Immunology Reviews (Discontinued) PI3K-Akt Signaling and Viral Infection
Recent Patents on Biotechnology